A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung ...
This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
Prism Johnson Ltd., incorporated in the year 1992, is a Mid Cap company (having a market cap of Rs 7,612.76 Crore) operating in Cement sector. Prism Johnson Ltd. key Products/Revenue Segments include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback